Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Crohn's Disease |
Crohn's disease; Crohn//'s disease; Inflamatory Bowel Disease; Inflammatory Bowel Disease, Crohn's |
Clinical Trial: Multicenter Trial For Patients With Acute Crohn's Disease
This study has been completed.
|
Purpose
The purpose of this study is to see if etiprednol dicloacetate is safe and effective for the treatment of acute Crohn's disease.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Crohn's Disease | Drug: etiprednol dicloacetate | Phase II |
MedlinePlus related topics: Crohn's Disease
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Pharmacodynamics Study
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
- Must have active confirmed Crohn's disease with CDAI > 220 and < 400.
- Otherwise healthy.
Location Information
California
Stuart Weisman, Palo Alto, California, 94304, United States
Colorado
University of Colorado Medical Center, Denver, Colorado, 80262, United States
District of Columbia
Washington Hospital Center, Washington, District of Columbia, 20010, United States
Florida
Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States
Wayne Schonfeld, Hollywood, Florida, 33021, United States
Mark Lamet, Hollywood, Florida, 33021, United States
Illinois
University of Chicago Hospital Medical Center, Chicago, Illinois, 60637, United States
Kentucky
Gerald Dryden, Louisville, Kentucky, 40202, United States
New York
Richard MacDermott, Albany, New York, 12208, United States
Canada, Ontario
Hillary Steinhart, Toronto, Ontario, M5G 1XB, Canada
Canada, Quebec
Gary Wild, Montreal, Quebec, H3G 1A4, Canada
More Information
Study ID Numbers: IXR-201-19-166
Record last reviewed: October 2003
Last Updated: October 26, 2004
Record first received: May 3, 2002
ClinicalTrials.gov Identifier: NCT00035503
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: October 2003
Last Updated: October 26, 2004
Record first received: May 3, 2002
ClinicalTrials.gov Identifier: NCT00035503
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
